Skip to main content
Signal8
Kaye Mark profile photo

Mark Kaye

CIK: 0001748691

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)14 (45.2%)

Position reduction

Option Exercises (M)2 (6.5%)

Derivative conversions

Awards (A)9 (29.0%)

Compensation grants

Other (G, F, J, C, D, …)6 (19.4%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Elevance Health, Inc. logo
ELV

Elevance Health, Inc.

Officer
CONMED Corp logo
CNMD

CONMED Corp

Director

Discretionary Trading P&L

Holdings

Transaction History (31 total)

  • Elevance Health, Inc. logo
    ELV

    Elevance Health, Inc.

    Oct 22, 2026
    Sale(S)
    Direct
    400 shares at avg. $434.00$174K
  • Elevance Health, Inc. logo
    ELV

    Elevance Health, Inc.

    Oct 22, 2026
    Sale(S)
    Direct
    321 shares at avg. $435.25$140K
  • Elevance Health, Inc. logo
    ELV

    Elevance Health, Inc.

    Oct 22, 2026
    Sale(S)
    Direct
    1.7K shares at avg. $436.20$724K
  • Elevance Health, Inc. logo
    ELV

    Elevance Health, Inc.

    Oct 22, 2026
    Sale(S)
    Direct
    560 shares at avg. $437.07$245K
  • Elevance Health, Inc. logo
    ELV

    Elevance Health, Inc.

    Oct 22, 2026
    Sale(S)
    Direct
    240 shares at avg. $438.22$105K
  • Elevance Health, Inc. logo
    ELV

    Elevance Health, Inc.

    Oct 22, 2026
    Sale(S)
    Direct
    1.2K shares at avg. $439.25$510K
  • Elevance Health, Inc. logo
    ELV

    Elevance Health, Inc.

    Oct 22, 2026
    Sale(S)
    Direct
    1.7K shares at avg. $440.44$758K
  • Elevance Health, Inc. logo
    ELV

    Elevance Health, Inc.

    Oct 22, 2026
    Sale(S)
    Direct
    2.3K shares at avg. $441.34$1.0M
  • Elevance Health, Inc. logo
    ELV

    Elevance Health, Inc.

    Oct 22, 2026
    Sale(S)
    Direct
    480 shares at avg. $442.61$212K
  • Elevance Health, Inc. logo
    ELV

    Elevance Health, Inc.

    Oct 22, 2026
    Sale(S)
    Direct
    440 shares at avg. $443.81$195K
  • Elevance Health, Inc. logo
    ELV

    Elevance Health, Inc.

    Oct 22, 2026
    Sale(S)
    Direct
    160 shares at avg. $444.85$71K
  • Elevance Health, Inc. logo
    ELV

    Elevance Health, Inc.

    Oct 22, 2026
    Sale(S)
    Direct
    827 shares at avg. $446.05$369K
  • Elevance Health, Inc. logo
    ELV

    Elevance Health, Inc.

    Oct 22, 2026
    Sale(S)
    Direct
    273 shares at avg. $447.19$122K
  • Elevance Health, Inc. logo
    ELV

    Elevance Health, Inc.

    Oct 2, 2026
    Tax Payment(F)
    Direct
    4.2K shares at avg. $386.43$1.6M
  • Elevance Health, Inc. logo
    ELV

    Elevance Health, Inc.

    Oct 2, 2026
    Award(A)
    Direct
    2.6K shares-
  • CONMED Corp logo
    CNMD

    CONMED Corp

    Jun 2, 2026
    Exercise(M)
    Direct
    668 shares-
  • CONMED Corp logo
    CNMD

    CONMED Corp

    Jun 1, 2026
    Award(A)

    RSUs (Restricted Stock Units)

    Direct
    5.8K shares-
  • Elevance Health, Inc. logo
    ELV

    Elevance Health, Inc.

    Mar 3, 2026
    Tax Payment(F)
    Direct
    353 shares at avg. $284.03$100K
  • Elevance Health, Inc. logo
    ELV

    Elevance Health, Inc.

    Mar 2, 2026
    Tax Payment(F)
    Direct
    271 shares at avg. $294.07$80K
  • Elevance Health, Inc. logo
    ELV

    Elevance Health, Inc.

    Mar 2, 2026
    Award(A)
    Direct
    6.4K shares-
  • Elevance Health, Inc. logo
    ELV

    Elevance Health, Inc.

    Mar 2, 2026
    Award(A)
    Direct
    10.2K shares-
  • CONMED Corp logo
    CNMD

    CONMED Corp

    Feb 24, 2026
    Exercise(M)
    Direct
    152 shares-
  • Elevance Health, Inc. logo
    ELV

    Elevance Health, Inc.

    Oct 2, 2025
    Tax Payment(F)
    Direct
    2.9K shares at avg. $340.24$985K
  • CONMED Corp logo
    CNMD

    CONMED Corp

    Jun 2, 2025
    Award(A)

    Options To Purchase Common Stock

    Direct
    8.1K shares-
  • CONMED Corp logo
    CNMD

    CONMED Corp

    Jun 2, 2025
    Award(A)

    RSUs (Restricted Stock Units)

    Direct
    668 shares-

1-25 of 31

About Kaye Mark

Kaye Mark (SEC CIK 0001748691) files insider reports with the SEC as EVP & CFO of Elevance Health, Inc. (ELV) and Director of CONMED Corp (CNMD).

Signal8 holds 12 ownership filings by Kaye Mark (1 Form 3, 11 Form 4), filed between Oct 4, 2024 and Oct 23, 2026. Those filings report 31 transactions, from Oct 2, 2024 to Oct 22, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Kaye Mark's filings is in INDIANAPOLIS, IN.

Recent filings by Kaye Mark

  • Oct 22, 2026: Open-market sales of ELV shares (13 lines, Form 4, code S).
  • Oct 2, 2026: Tax withholding of ELV shares (Form 4, code F).
  • Oct 2, 2026: Grant or award of ELV shares (Form 4, code A).
  • Jun 2, 2026: Option exercise of CNMD shares (Form 4, code M).
  • Jun 1, 2026: Grant or award of CNMD derivative securities (Form 4, code A).

Other insiders filing for Elevance Health, Inc. (ELV)

How to read Form 4 transaction codes